A triphosphorylated species may be linked to DNA repair. A site-specific proteomics approach holds promise for Alzheimer’s diagnosis. A new platform improves quantification of histone modifications.

“The central idea is that if you alter the composition of the cell membrane, you can potentially alter the functionality of the proteins within the membrane and thus the disease overall.”

Studies have linked virus susceptibility and severity to genes inherited from Neanderthals and to blood type — but not all researchers agree on the results.

A study in the United Kingdom has identified four novel genetic variants associated with critical illness in patients with COVID-19.

As a JBC Herbert Tabor Early Career Investigator Award recipient, James Burke will present his work at the 2021 ASBMB Annual Meeting.

“My grandmother meant the world to me. Nothing could have prepared me for her death or the anger I directed at myself for being unable to help her during her final months.”

Protein profiles offer new insights into Duchenne muscular dystrophy. A novel fungal protease improves proteomic coverage. Expression of HLA-II shows promise for immunotherapy.

The cell-aging enzyme’s RNA is an intermediate between that of humans and lower eukaryotes, containing signature marks from both kingdoms.

A new tracing method described in the Journal of Lipid Research offers clues on how a macronutrient interacts with the microbes that live inside us.

The ASBMB honors an Emory University professor and trailblazer who is passionate about increasing diversity and inclusion in science.

Benjamin Garcia’s research group at the University of Pennsylvania has developed novel methodologies to analyze histones for application in post-translational modifications and systems epigenetics.

JBC/Tabor Award winner Kirstine Lavrsen identified an important role for a posttranslational modification enzyme in conversion of normal colon tissue into cancerous tissue.